# FDA 483 - FUJIFILM Diosynth Biotechnologies Texas, LLC - November 07, 2023

Source: https://www.globalkeysolutions.net/records/483/fujifilm-diosynth-biotechnologies-texas-llc/7cfae829-7bda-43cf-8735-e68e7f640223

> FDA 483 for FUJIFILM Diosynth Biotechnologies Texas, LLC on November 07, 2023. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: FUJIFILM Diosynth Biotechnologies Texas, LLC
- Inspection Date: 2023-11-07
- Product Type: biologics
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2025-03-11](https://www.globalkeysolutions.net/records/483/fujifilm-diosynth-biotechnologies-texas-llc/af971cdd-2070-4cfa-95e8-7063d7de814b)
- [483 - 2023-11-07](https://www.globalkeysolutions.net/records/483/fujifilm-diosynth-biotechnologies-texas-llc/5988d09b-a683-45ba-810e-8485a833ff66)
- [483 - 2023-06-07](https://www.globalkeysolutions.net/records/483/fujifilm-diosynth-biotechnologies-texas-llc/0f4430c6-83ef-4a5a-8a11-157a63dafd35)
- [483 - 2021-08-31](https://www.globalkeysolutions.net/records/483/fujifilm-diosynth-biotechnologies-texas-llc/5ddeda20-1d32-47ce-8331-f65349a3e375)
- [483 - 2023-11-07](https://www.globalkeysolutions.net/records/483/fujifilm-diosynth-biotechnologies-texas-llc/77895ddb-3f0d-41f4-be7f-82f98a0b9e2a)

## Related Officers

- [Emine GuvenMaiorov](https://www.globalkeysolutions.net/people/emine-guvenmaiorov/00186865-3b56-4115-8c4b-cea8072a314b)
- [Yiwei Li](https://www.globalkeysolutions.net/people/yiwei-li/e5ea2c24-8e1e-43be-be23-e276b8848cff)
- [Jun Liu](https://www.globalkeysolutions.net/people/jun-liu/39e5d6f3-32fd-426f-880d-3d840a9faed2)
- [Senior Regulatory Specialist](https://www.globalkeysolutions.net/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.globalkeysolutions.net/companies/fujifilm-diosynth-biotechnologies-texas-llc/5411232a-c284-4b0d-b955-09e32761748f

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd